Welcome back to the Injective Overview. We’re creating the best place for the Injective community to get the latest updates, metrics, insights and ecosystem developments and more – all in one place.
New here? Subscribe to get updates to your inbox, every other Monday.
Injective By The Numbers
$INJ price: $4.43 (-12.5%)
Token market cap: $442M (-12.4%)
Total $INJ staked: 57.6M (-0.2%)
Staking APR: 6.17% (-50.2%)
Injective daily trading volume: $19.8M (-42.2%)
The percentages and metrics are calculated from its change over a 14-day time frame, unless noted otherwise.
Injecting The Biggest Developments
Highlighting some of the largest announcements from Injective.
🥷 What’s happening: Injective’s community has approved the IIP-617 governance proposal, which changes how new INJ tokens are issued. The update, called the INJ Supply Squeeze, will permanently reduce the rate at which new INJ tokens enter circulation, effectively doubling the network’s deflation rate.
🥷 Why it matters: Unlike temporary programs or one-off burns, the change adjusts issuance rules at the protocol level, controlling how supply evolves over time.
By issuing fewer tokens and continuing regular buybacks and burns through the Community BuyBack program, Injective will reduce the amount of INJ in circulation at a faster pace than before.
This links supply changes more directly to network activity: when the protocol generates revenue, some of it will be used to buy INJ from the market and remove it permanently, while fewer tokens are added.
🥷 The bigger picture: As more activity moves onchain, Injective’s Supply Squeeze aims to ensure that increased usage will affect token supply in a more consistent and measurable way.
Other networks, such as Ethereum, have introduced a similar practice: instead of relying solely on fixed issuance, the blockchain began burning a portion of transaction fees, so higher usage could lead to lower net supply growth.
While Ethereum’s price performance still depended largely on demand and broader market conditions, the change altered how supply behaved over time and made issuance more sensitive to real usage. Injective’s Supply Squeeze looks to follow a similar path by hard-coding tighter issuance rules and pairing them with ongoing burns.
Expanding The Financial Ecosystem
Updates on the latest network of dApps, validators, builders and more helping Injective expand its financial use cases.
January has been Injective’s best performing month of all-time, with active users averaging 87.8K so far this month
Dappbuilder integrated Claude Code, letting users to build applications using text prompts
Injective’s January Community BuyBack saw $198K in INJ tokens removed from supply, yielding BuyBack participants an impressive 27% return.
Korea University’s Blockchain Research Institute has struck a partnership to bring on Injective as a research collaborator and network validator
From The Injective Ninjas 🥷
Highlighting the builders, communities and ecosystem players within the Injective blockchain.
Check out the startups chosen from Injective and Outlier Ventures’ nine-week ecosystem builder catalyst campaign
Helix released a delta-neutral hedging tool that tracks funding rates across different exchanges and Helix-supported tokens
Hydro surpassed 231K mints of its yield-bearing liquid staking token on Injective
Cooper Emmons, institutional lead at Injective, spoke on Taking Stock at the New York Stock Exchange about onchain perpetuals
Dive Deeper Into Injective
Want to get involved in the ecosystem?
Check out the Cointelegraph Accelerator, a 12-week program offering grant funding and mentorship to ecosystem founders
Paradyze has launched a six-week trading competition featuring a $50K prize pool
Until next time!
To get this newsletter delivered to your inbox, subscribe here:
This product was built by Token Relations.
This information is for entertainment purposes only. It should not be considered financial advice, nor should it be used to make investment decisions. Cryptocurrencies are high risk and you should consult a financial professional before making any financial decisions. Make sure you do your own research.